Email: cspc@cspc.cn

Contact Us
EN

News

News

Home > Media > News > LEUPRORELIN EXTENDED-RELEASE INJECTION (SYH9016) OBTAINS CLINICAL TRIAL APPROVAL

LEUPRORELIN EXTENDED-RELEASE INJECTION (SYH9016) OBTAINS CLINICAL TRIAL APPROVAL

December 30, 2024

a241230_00.png

a241230_01.png

Previous: SYS6010 WAS GRANTED BREAKTHROUGH THERAPY DESIGNATION IN CHINA

Next: SYH2062 INJECTION (siRNA DRUG) OBTAINS CLINICAL TRIAL APPROVAL

Contact Us

Phone:

+86 311 8703 7015

Email:

cspc@cspc.cn

Products

Science

About Us

Legal terms Privacy protection
Copyright © CSPC Pharmaceutical Group Co., Ltd. All Rights Reserved |

Wechat